Patents Assigned to NUMT INC.
  • Adipocytes over-expressing FFAR4 and use thereof
    Patent number: 12569539
    Abstract: Provided herein is a method for treating and/or preventing various diseases including a decrease in glucose tolerance and a decrease in cognitive ability associated with aging with adipocytes over-expressing FFAR4 and a transplant composition including the adipocytes.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: March 10, 2026
    Assignees: NUMT INC., TOHO UNIVERSITY
    Inventors: Yoshinori Takei, Akira Hirasawa